Media Downloads

White Paper: The Evolving Role of Antigen Testing in the COVID-19 Pandemic Response

The report reviews the two basic types of diagnostic tests exist for SARS-CoV-2 virus detection, for which the US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs):

  • Polymerase chain reaction (PCR) tests—also referred to as reverse transcription PCR (RT-PCR) tests—use a laboratory-based molecular approach to detect genetic material (ribonucleic acid, or RNA) from the virus in a nasal or throat swab or in saliva.
  • Antigen tests, which may be performed at the point of care, detect specific proteins on or within the virus by testing a nasal swab or saliva sample.

The Pandemic Defense and Economic Recovery System

From sports stadiums, airlines, cruise ships, and concert venues to healthcare facilities, corporate campuses, and universities,  to safely open to full capacity and maintain business continuity every environment requires:

  • accurate
  • affordable
  • accessible
  • fast
  • scalable technology


Latest Investor Presentation - January 14, 2020

We are developing a revolutionary Pandemic Defense and Economic Recovery System that will usher in the ‘the new normal’. It’s first testing system will be Antigen based with a throughput capacity of 2,500 tests per hour. Preliminary LOD 90x lower than the nearest competitor.

Please join Bill Phelan, CEO of FluroTest for an executive presentation on the FluroTest Pandemic Defense and Economic Recovery Platform

In the News

Media & Press Inquiries

To get in touch with the Press Team at FluroTest, please fill out the contact form with your press inquiry and our team will be in touch.